Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of C$7.32 and traded as low as C$7.10. Eupraxia Pharmaceuticals shares last traded at C$7.25, with a volume of 1,015,479 shares changing hands.
Eupraxia Pharmaceuticals Trading Down 5.8%
The business’s fifty day moving average price is C$7.54 and its 200 day moving average price is C$7.32.
About Eupraxia Pharmaceuticals
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing locally administered therapies for inflammatory and fibrotic diseases. The company’s programs are designed to deliver active pharmaceutical ingredients directly to affected tissues while potentially limiting systemic exposure and associated side effects.
Eupraxia’s development platform uses a proprietary diffusion-based hydrogel technology intended to provide controlled, sustained drug release.
Recommended Stories
- Five stocks we like better than Eupraxia Pharmaceuticals
- L3Harris Stock Took a Beating—Is a 20% Rebound Next?
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
Receive News & Ratings for Eupraxia Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eupraxia Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
